Approval · Notice of Compliance 24728 · 2020
PROGRAF: Notice of Compliance 24728
Issued December 2, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24728
- Date
- December 2, 2020
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the product monograph with drug interactions with clarithromycin and sofosbuvir
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGRAF | Not yet assigned | — |
Medicinal ingredients
- TACROLIMUS 0.5 MG per CAP
- TACROLIMUS 1 MG per CAP
- TACROLIMUS 5 MG per CAP
- TACROLIMUS 5 MG per ML